Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Tong
State University New York Stony Brook, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Chronus Pharmaceuticals
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Tonge holds an equity interest in Chronus Pharmaceuticals. Chronus Pharmaceuticals would be interested in licensing potential intellectual property from this project at a later stage.
Establishing a Long Island Bioscience Hub
�� ESTABLISHING A LONG ISLAND BIOSCIENCE HUB: NARRATIVE Stony Brook University, Cold Spring Harbor Laboratory, and Brookhaven National Laboratory are proposing to form Long Island Bioscience Hub (LIBH), to accelerate the translation of basic science and engineering research into bio-based technologies and companies. Individually and collectively, these institutions have a demonstrated capacity for bioscience innovation that has advanced the course of biomedical science and contributed to improved healthcare through a range of FDA approved therapies and diagnostics, ranging from small molecule therapeutics to diagnostic devices. The LIBH will provide the infrastructure, technology development and educational programs to augment and expedite this process, simultaneously providing the foundation for a vibrant bioscience industry cluster.
Filed on December 12, 2017.
Tell us what you know about Peter Tong's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Peter Tong”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Tonge | State University New York Stony Brook | Conflict of Interest | Chronus Pharmaceuticals | Value cannot be readily determined |
| Peter Tonge | State University New York Stony Brook | Conflict of Interest | Chronus Pharamceuticals | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.